Dorsal striatal hypoconnectivity predicts antipsychotic medication treatment response in first‐episode psychosis and unmedicated patients with schizophrenia

Abstract Introduction The dorsal striatum, comprised of the caudate and putamen, is implicated in the pathophysiology of psychosis spectrum disorders. Given the high concentration of dopamine receptors in the striatum, striatal dopamine imbalance is a likely cause in cortico‐striatal dysconnectivity...

Full description

Bibliographic Details
Main Authors: Eric A. Nelson, Nina V. Kraguljac, Jose O. Maximo, William Armstrong, Adrienne C. Lahti
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Brain and Behavior
Subjects:
Online Access:https://doi.org/10.1002/brb3.2625
_version_ 1811178203025244160
author Eric A. Nelson
Nina V. Kraguljac
Jose O. Maximo
William Armstrong
Adrienne C. Lahti
author_facet Eric A. Nelson
Nina V. Kraguljac
Jose O. Maximo
William Armstrong
Adrienne C. Lahti
author_sort Eric A. Nelson
collection DOAJ
description Abstract Introduction The dorsal striatum, comprised of the caudate and putamen, is implicated in the pathophysiology of psychosis spectrum disorders. Given the high concentration of dopamine receptors in the striatum, striatal dopamine imbalance is a likely cause in cortico‐striatal dysconnectivity. There is great interest in understanding the relationship between striatal abnormalities in psychosis and antipsychotic treatment response, but few studies have considered differential involvement of the caudate and putamen. This study's goals were twofold. First, identify patterns of dorsal striatal dysconnectivity for the caudate and putamen separately in patients with a psychosis spectrum disorder; second, determine if these dysconnectivity patterns were predictive of treatment response. Methods Using resting state functional connectivity, we evaluated dorsal striatal connectivity using separate bilateral caudate and putamen seed regions in two cohorts of subjects: a cohort of 71 medication‐naïve first episode psychosis patients and a cohort of 42 unmedicated patients with schizophrenia (along with matched controls). Patient and control connectivity maps were contrasted for each cohort. After receiving 6 weeks of risperidone treatment, patients’ clinical response was calculated. We used regression analyses to determine the relationship between baseline dysconnectivity and treatment response. Results This dysconnectivity was also predictive of treatment response in both cohorts. Discussion These findings suggest that the caudate may be more of a driving factor than the putamen in early cortico‐striatal dysconnectivity.
first_indexed 2024-04-11T06:14:31Z
format Article
id doaj.art-b9901c20360247c9bfd63eab08368d04
institution Directory Open Access Journal
issn 2162-3279
language English
last_indexed 2024-04-11T06:14:31Z
publishDate 2022-11-01
publisher Wiley
record_format Article
series Brain and Behavior
spelling doaj.art-b9901c20360247c9bfd63eab08368d042022-12-22T04:41:06ZengWileyBrain and Behavior2162-32792022-11-011211n/an/a10.1002/brb3.2625Dorsal striatal hypoconnectivity predicts antipsychotic medication treatment response in first‐episode psychosis and unmedicated patients with schizophreniaEric A. Nelson0Nina V. Kraguljac1Jose O. Maximo2William Armstrong3Adrienne C. Lahti4Department of Psychiatry and Behavioral Neurobiology University of Alabama at Birmingham Birmingham Alabama USADepartment of Psychiatry and Behavioral Neurobiology University of Alabama at Birmingham Birmingham Alabama USADepartment of Psychiatry and Behavioral Neurobiology University of Alabama at Birmingham Birmingham Alabama USADepartment of Psychiatry and Behavioral Neurobiology University of Alabama at Birmingham Birmingham Alabama USADepartment of Psychiatry and Behavioral Neurobiology University of Alabama at Birmingham Birmingham Alabama USAAbstract Introduction The dorsal striatum, comprised of the caudate and putamen, is implicated in the pathophysiology of psychosis spectrum disorders. Given the high concentration of dopamine receptors in the striatum, striatal dopamine imbalance is a likely cause in cortico‐striatal dysconnectivity. There is great interest in understanding the relationship between striatal abnormalities in psychosis and antipsychotic treatment response, but few studies have considered differential involvement of the caudate and putamen. This study's goals were twofold. First, identify patterns of dorsal striatal dysconnectivity for the caudate and putamen separately in patients with a psychosis spectrum disorder; second, determine if these dysconnectivity patterns were predictive of treatment response. Methods Using resting state functional connectivity, we evaluated dorsal striatal connectivity using separate bilateral caudate and putamen seed regions in two cohorts of subjects: a cohort of 71 medication‐naïve first episode psychosis patients and a cohort of 42 unmedicated patients with schizophrenia (along with matched controls). Patient and control connectivity maps were contrasted for each cohort. After receiving 6 weeks of risperidone treatment, patients’ clinical response was calculated. We used regression analyses to determine the relationship between baseline dysconnectivity and treatment response. Results This dysconnectivity was also predictive of treatment response in both cohorts. Discussion These findings suggest that the caudate may be more of a driving factor than the putamen in early cortico‐striatal dysconnectivity.https://doi.org/10.1002/brb3.2625caudateconnectivityfirst episodepsychosisputamenresting state
spellingShingle Eric A. Nelson
Nina V. Kraguljac
Jose O. Maximo
William Armstrong
Adrienne C. Lahti
Dorsal striatal hypoconnectivity predicts antipsychotic medication treatment response in first‐episode psychosis and unmedicated patients with schizophrenia
Brain and Behavior
caudate
connectivity
first episode
psychosis
putamen
resting state
title Dorsal striatal hypoconnectivity predicts antipsychotic medication treatment response in first‐episode psychosis and unmedicated patients with schizophrenia
title_full Dorsal striatal hypoconnectivity predicts antipsychotic medication treatment response in first‐episode psychosis and unmedicated patients with schizophrenia
title_fullStr Dorsal striatal hypoconnectivity predicts antipsychotic medication treatment response in first‐episode psychosis and unmedicated patients with schizophrenia
title_full_unstemmed Dorsal striatal hypoconnectivity predicts antipsychotic medication treatment response in first‐episode psychosis and unmedicated patients with schizophrenia
title_short Dorsal striatal hypoconnectivity predicts antipsychotic medication treatment response in first‐episode psychosis and unmedicated patients with schizophrenia
title_sort dorsal striatal hypoconnectivity predicts antipsychotic medication treatment response in first episode psychosis and unmedicated patients with schizophrenia
topic caudate
connectivity
first episode
psychosis
putamen
resting state
url https://doi.org/10.1002/brb3.2625
work_keys_str_mv AT ericanelson dorsalstriatalhypoconnectivitypredictsantipsychoticmedicationtreatmentresponseinfirstepisodepsychosisandunmedicatedpatientswithschizophrenia
AT ninavkraguljac dorsalstriatalhypoconnectivitypredictsantipsychoticmedicationtreatmentresponseinfirstepisodepsychosisandunmedicatedpatientswithschizophrenia
AT joseomaximo dorsalstriatalhypoconnectivitypredictsantipsychoticmedicationtreatmentresponseinfirstepisodepsychosisandunmedicatedpatientswithschizophrenia
AT williamarmstrong dorsalstriatalhypoconnectivitypredictsantipsychoticmedicationtreatmentresponseinfirstepisodepsychosisandunmedicatedpatientswithschizophrenia
AT adrienneclahti dorsalstriatalhypoconnectivitypredictsantipsychoticmedicationtreatmentresponseinfirstepisodepsychosisandunmedicatedpatientswithschizophrenia